Skip to main content

Table 2 Vitamin D levels, status, and intake among studied groups

From: Impact of vitamin D status on CF and non-CF bronchiectasis outcomes

 

Non-CF bronchiectasis (group I)

CF bronchiectasis (group II)

Controls (group III)

P value

Post hoc

Serum vitamin D level, mean ± SD

20.85±7.21

20.15±11.66

35.15±12.84

<0.001

(I vs III) **

(II vs III)**

Vitamin D level status, n (%)

Deficient

9(45.0%)

15(75.0%)

2(10.0%)

<0.001#

(II vs III)** (I vs III)*

Insufficient

8(40.0%)

4(20.0%)

7(35.0%)

Sufficient

3(15.0%)

1(5.0%)

11(55.0%)

Daily dietary intake of vitamin D (IU) (mean ± SD)

338.50±62.17

313.80±65.66

357.25±40.54

0.063

(II vs III) *

Vitamin D dietary intake % of RDA (mean ± SD)

56.42±10.36

56.85±6.90

60.39±9.75

0.467

 

Sun exposure, N (%)

Adequate

6 (30.0%)

3 (15.0%)

8 (40.0%)

0.552#

 

Inadequate

14 (70.0%)

17 (85.0%)

12 (60.0%)

  1. RDA recommended daily allowance. *Significant, **highly significant, ANOVA, #chi-square test